Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts

被引:0
|
作者
Takahashi, Y
Akanuma, Y
Yazaki, Y
Kadowaki, T
机构
[1] Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138655, Japan
[2] Asahi Life Fdn, Inst Diabet Care & Res, Tokyo, Japan
关键词
D O I
10.1002/(SICI)1097-4652(199901)178:1<69::AID-JCP9>3.0.CO;2-Z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We recently described a better correlation of DNA synthesis with phosphatidylinositol (PI) 3-kinase than with mitogen-activated protein (MAP) kinase stimulated by insulin-like growth factor (IGF)-1 or epidermal growth factor (EGF) in human skin fibroblasts (Takahashi et al., 1997, Endocrinology 138:747-750). IGF-1-induced PI 3-kinase activation is generally mediated via insulin receptor substrate (IRS)-1, but EGF-induced PI 3-kinase activation is mediated by various signalling molecules such as ErbB3 and c-Cbl in different cells. We therefore investigated the mechanism regulating PI 3-kinase in human skin fibroblasts by comparing complexes involving PI 3-kinase when stimulated by IGF-1 or EGF and found that p115 and p105, which were tyrosine-phosphorylated by EGF stimulation and associated with SHP-2, were also associated with the p85 subunit of PI 3-kinase by EGF. Anti-SHP-2 and anti-p85 subunits of PI 3-kinase antibodies did not coprecipitate tyrosine-phosphorylated EGF receptor or ErbB3; in addition, p115 and p105 appeared to be distinct from tyrosine-phosphorylated c-Cbl. Thus, tyrosine-phosphorylated p115 and p105 may provide a novel platform recruiting p85, which may simultaneously bind to SHP-2. in contrast, tyrosine phosphorylation of p115 or p105 was undetectable by immunoblot with IGF-1 stimulation, and PI 3-kinase activity was mediated via IRS-1 phosphorylated with IGF-1 stimulation, little of which was associated with SHP-2. Thus, EGF and IGF-1 cause formation of a distinct signalling complex which associates with p85 subunit of Pi 3-kinase. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [41] STUDY OF INSULIN-LIKE GROWTH FACTOR-I IN HUMAN OBESITY
    CORDIDO, F
    CASANUEVA, FF
    VIDAL, JI
    DIEGUEZ, C
    HORMONE RESEARCH, 1991, 36 (5-6) : 187 - 191
  • [42] INSULIN-LIKE GROWTH FACTOR-I RECEPTORS AND INSULIN-LIKE GROWTH FACTOR-1-LIKE ACTIVITY IN HUMAN PRIMARY BREAST-CANCER
    FOEKENS, JA
    PORTENGEN, H
    JANSSEN, M
    KLIJN, JGM
    CANCER, 1989, 63 (11) : 2139 - 2147
  • [43] Stimulation of the peptide YY gene by insulin-like growth factor-I
    Udupi, V
    Lee, HM
    Englander, E
    Leiter, A
    Greeley, GH
    GASTROENTEROLOGY, 1999, 116 (04) : A652 - A652
  • [44] A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo
    Ji, Qun-Sheng
    Mulvihill, Mark J.
    Rosenfeld-Franklin, Maryland
    Cooke, Andrew
    Feng, Lixin
    Mak, Gilda
    O'Connor, Matthew
    Yao, Yan
    Pirritt, Caroline
    Buck, Elizabeth
    Eyzaguirre, Alexandra
    Arnold, Lee D.
    Gibson, Neil W.
    Pachter, Jonathan A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2158 - 2167
  • [45] EXPRESSION OF GROWTH-HORMONE RECEPTOR, INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-I RECEPTOR IN HUMAN SKIN MAY EXPLAIN THE ABILITY OF SYSTEMICALLY ADMINISTERED GROWTH-HORMONE TO THICKEN HUMAN SKIN
    TAVAKKOL, A
    KEANE, KM
    GRIFFITHS, CEM
    FISHER, GJ
    VOORHEES, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (04) : 563 - 563
  • [46] PURIFICATION OF HUMAN INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II
    ZUMSTEIN, PP
    HUMBEL, RE
    METHODS IN ENZYMOLOGY, 1985, 109 : 782 - 798
  • [47] Insulin-like growth factor-I in wound healing of rat skin
    Todorovic, Vera
    Pesko, Predrag
    Micev, Marjan
    Bjelovic, Milos
    Budec, Mirela
    Micic, Mileva
    Brasanac, Dimitrije
    Ilic-Stojanovic, Olivera
    REGULATORY PEPTIDES, 2008, 150 (1-3) : 7 - 13
  • [48] EXPRESSION OF GROWTH-HORMONE RECEPTOR, INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-I RECEPTOR IN HUMAN SKIN MAY EXPLAIN THE ABILITY OF SYSTEMICALLY ADMINISTERED GROWTH-HORMONE TO THICKEN HUMAN SKIN
    TAVAKKOL, A
    KEANE, KM
    GRIFFITHS, CEM
    FISHER, GJ
    VOORHEES, JJ
    CLINICAL RESEARCH, 1991, 39 (02): : A495 - A495
  • [49] INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II
    HUMBEL, RE
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (03): : 445 - 462
  • [50] Activation of protein kinase C-ζ and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I
    Liu, Q
    Ning, W
    Dantzer, R
    Freund, GG
    Kelley, KW
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1393 - 1401